↓ Skip to main content

Availability, accessibility and delivery to patients of the 28 orphan medicines approved by the European Medicine Agency for hereditary metabolic diseases in the MetabERN network

Overview of attention for article published in Orphanet Journal of Rare Diseases, January 2020
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

twitter
19 X users

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
64 Mendeley